Company Filing History:
Years Active: 2020-2024
Title: Masato Amano: Innovator in Tumor Therapy
Introduction
Masato Amano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of tumor therapy through his innovative research and development of antibodies. With a total of 6 patents to his name, Amano is recognized for his dedication to advancing medical science.
Latest Patents
Amano's latest patents include the development of an Anti-GARP antibody. This invention relates to an antibody that binds to GARP and serves as a therapeutic agent for tumors. The antibody inhibits the function of Treg in tumors, providing a pharmaceutical product with therapeutic effects. Additionally, he has developed an Anti-CD147 antibody, which exhibits potent antitumor efficacy and excellent safety. This antibody activates CD147 and provides a method for treating tumors, showcasing Amano's commitment to improving cancer treatment options.
Career Highlights
Masato Amano is currently associated with Daiichi Sankyo Company, Limited, where he continues to work on groundbreaking research in the field of oncology. His innovative approaches have positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Amano collaborates with talented coworkers, including Kazuki Satoh and Kazuki Hirahara. Their combined expertise enhances the research and development efforts at Daiichi Sankyo Company, Limited.
Conclusion
Masato Amano's contributions to tumor therapy through his innovative patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in cancer treatment.